Nesfatin-1 exerts a direct, glucose-dependent insulinotropic action on mouse islet β- and MIN6 cells

Journal of Endocrinology

Volumn 208, Issue 3, 2011, Pages

  Gonzalez, Ronald ^a   Reingold, Benjamin K ^a   Gao, Xiaodong ^a   Gaidhu, Mandeep P ^a   Tsushima, Robert G ^a   Unniappan, Suraj ^a  

^a YORK UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; MESSENGER RNA; NESFATIN 1; NUCLEOBINDIN 2; PANCREAS HORMONE; PROTEIN PRECURSOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ISOLATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE EXPRESSION; HORMONE RELEASE; IMMUNOREACTIVITY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN LIKE ACTIVITY; INSULIN RELEASE; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; STREPTOZOCIN DIABETES;

ANIMALS; CALCIUM-BINDING PROTEINS; CELL LINE; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DNA-BINDING PROTEINS; GLUCAGON; GLUCOSE; INSULIN; INSULIN-SECRETING CELLS; MALE; MICE; MICE, INBRED C57BL; NERVE TISSUE PROTEINS; OBESITY;

EID: 79951803034     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-10-0492     Document Type: Article

References (23)

1. Atsuchi K, Asakawa A, Ushikai M, Ataka K, Tsai M, Koyama K, Sato Y, Kato I, Fujimiya M & Inui A 2010 Centrally administered nesfatin-1 inhibits feeding behaviour and gastroduodenal motility in mice. Neuroreport 21 1008-1011. (doi:10.1097/WNR.0b013e32833f7b96)
2. Bock T, Pakkenberg B & Buschard K 2003 Increased islet volume but unchanged islet number in ob/ob mice. Diabetes 52 1716-1722. (doi:10.2337/diabetes.52.7.1716)
3. Farilla L, Hui H, Bertolotto C, Kang E, Bulotta A, Di Mario U & Perfetti R 2002 Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats. Endocrinology 143 4397-4408. (doi:10.1210/en.2002-220405)
4. Foo KS, Brauner H, Ostenson CG & Broberger C 2010 Nucleobindin-2/nesfatin in the endocrine pancreas: distribution and relationship to glycaemic state. Journal of Endocrinology 204 255-263. (doi:10.1677/JOE-09- 0254)
5. Goebel M, Stengel A, Wang L, Lambrecht NW & Tache Y 2009 Nesfatin-1 immunoreactivity in rat brain and spinal cord autonomic nuclei. Neuroscience Letters 452 241-246. (doi:10.1016/j.neulet.2009.01.064)
6. Goebel M, Stengel A, Wang L & Tache Y 2010 Central nesfatin-1 reduces the nocturnal food intake in mice by reducing meal size and increasing intermeal intervals. Peptides 32 36-43. (doi:10.1016/j.peptides.2010.09.027)
7. Gonzalez R, Tiwari A & Unniappan S 2009 Pancreatic beta cells colocalize insulin and pronesfatin immunoreactivity in rodents. Biochemical and Biophysical Research Communications 381 643-648. (doi:10.1016/j.bbrc.2009.02. 104)
8. Iguchi H, Ikeda Y, Okamura M, Tanaka T, Urashima Y, Ohguchi H, Takayasu S, Kojima N, Iwasaki S, Ohashi R et al. 2005 SOX6 attenuates glucose-stimulated insulin secretion by repressing PDX1 transcriptional activity and is down-regulated in hyperinsulinemic obese mice. Journal of Biological Chemistry 280 7669-37680. (doi:10.1074/jbc.M505392200)
9. Kim W & Egan JM 2008 The role of incretins in glucose homeostasis and diabetes treatment. Pharmacological Reviews 60 470-512. (doi:10.1124/pr.108. 000604)
10. Li QC, Wang HY, Chen X, Guan HZ & Jiang ZY 2010 Fasting plasma levels of nesfatin-1 in patients with type 1 and type 2 diabetes mellitus and the nutrient-related fluctuation of nesfatin-1 level in normal humans. Regulatory Peptides 159 72-77. (doi:10.1016/j.regpep.2009.11.003)
11. Ogiso K, Asakawa A, Amitani H, Nakahara T, Ushikai M, Haruta I, Koyama KI, Amitani M, Harada T, Yasuhara D et al. 2010 Plasma nesfatin-1 concentrations in restricting-type anorexia nervosa. Peptides 32 150-153. (doi:10.1016/j. peptides.2010.10.004)
12. Oh-I S, Shimizu H, Satoh T, Okada S, Adachi S, Inoue K, Eguchi H, YamamotoM, Imaki T, Hashimoto K et al. 2006 Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature 443 709-712. (doi:10.1038/ nature05162)
13. Perfetti R, Zhou J, Doyle ME & Egan JM 2000 Glucagon-like peptide-1 induces cell proliferation and pancreatic-duodenum homeobox-1 expression and increases endocrine cell mass in the pancreas of old, glucose-intolerant rats. Endocrinology 141 4600-4605. (doi:10.1210/en.141.12.4600)
14. Pfaffl MW 2001 A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Research 29 e45. (doi:10.1093/nar/29.9.e45)
15. Reimer MK, Holst JJ & Ahren B 2002 Long-term inhibition of dipeptidyl peptidase IV improves glucose tolerance and preserves islet function in mice. European Journal of Endocrinology 146 717-727. (doi:10.1530/eje.0.1460717)
16. Shimizu H, Oh IS, Hashimoto K, Nakata M, Yamamoto S, Yoshida N, Eguchi H, Kato I, Inoue K, Satoh Tet al. 2009 Peripheral administration of nesfatin-1 reduces food intake in mice: the leptin-independent mechanism. Endocrinology 150 662-671. (doi:10.1210/en.2008-0598)
17. Stengel A, Goebel M, Wang L, Rivier J, Kobelt P, Monnikes H, Lambrecht NW & Tache Y 2009a Central nesfatin-1 reduces dark-phase food intake and gastric emptying in rats: differential role of corticotropin-releasing factor 2 receptor. Endocrinology 150 4911-4919. (doi:10.1210/en.2009-0578)
18. Stengel A, Goebel M, Yakubov I, Wang L, Witcher D, Coskun T, Tache Y, Sachs G & Lambrecht NW 2009b Identification and characterization of nesfatin-1 immunoreactivity in endocrine cell types of the rat gastric oxyntic mucosa. Endocrinology 150 232-238. (doi:10.1210/en.2008-0747)
19. Su Y, Zhang J, Tang Y, Bi F & Liu JN 2010 The novel function of nesfatin-1: anti-hyperglycemia. Biochemical and Biophysical Research Communications 391 1039-1042. (doi:10.1016/j.bbrc.2009.12.014)
20. Unniappan S, Wideman RD, Donald C, Gunn V, Wall JL, Zhang QX, Webber TD, Cheung AT & Kieffer TJ 2009 Treatment of diabetes by transplantation of drug-inducible insulin-producing gut cells. Journal of Molecular Medicine 87 703-712. (doi:10.1007/s00109-009-0465-0)
21. Winzell MS & Ahren B 2007 Role of VIP and PACAP in islet function. Peptides 28 1805-1813. (doi:10.1016/j.peptides.2007.04.024)
22. Yosten GL & Samson WK 2010 The anorexigenic and hypertensive effects of nesfatin-1 are reversed by pretreatment with an oxytocin receptor antagonist. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 298 R1642-R1647. (doi:10.1152/ajpregu.00804.2009)
23. Zhang Y, Liu Y, Qu J, Hardy A, Zhang N, Diao J, Strijbos PJ, Tsushima R, Robinson RB, Gaisano HY et al. 2009 Functional characterization of hyperpolarization-activated cyclic nucleotide-gated channels in rat pancreatic beta cells. Journal of Endocrinology 203 45-53. (doi:10.1677/JOE-09-0068)